Investor Relations

OPKO Announces Second Quarter Operating and Financial Results more »

Rayaldee Phase 3 Trial Meets Primary Endpoints more »

OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy more »

OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11, 2014 more »

Investor FAQs